Financial intermediary
Sofinnova Biovelocita II SLP
- Capital type
- Equity
- Provider
- EIF
- Country
- France
About
Sofinnova Biovelocita II SLP - EIF-backed equity intermediary under EIF Enabling sectors Sofinnova Partners SAS 7-11 boulevard Haussmann Paris Life science and health. Commitment: EUR 10,000,000.
Eligible geographies
- France
Programmes
- EIF Enabling sectors
Capital stack
- equity
Next
Most finance matches are advisory — we map eligibility, intermediaries, and related calls before you leave for an official portal.